Extrawell Pharmaceutical Holdings Limited (HKG:0858)
Hong Kong · Delayed Price · Currency is HKD 0.0870
+0.0040 (4.82%)
Jul 18, 2025, 1:44 PM HKT
HKG:0858 Revenue
In the fiscal year ending March 31, 2025, Extrawell Pharmaceutical Holdings had annual revenue of 55.43M HKD, down -6.21%.
Revenue
55.43M
Revenue Growth
-6.21%
P/S Ratio
3.58
Revenue / Employee
340.06K
Employees
163
Market Cap
198.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 55.43M | -3.67M | -6.21% |
| Mar 31, 2024 | 59.10M | -13.48M | -18.57% |
| Mar 31, 2023 | 72.58M | -1.35M | -1.82% |
| Mar 31, 2022 | 73.93M | -4.88M | -6.19% |
| Mar 31, 2021 | 78.80M | 1.22M | 1.57% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 28.99B |